professor miles fisher - the role of glp-1 – clinical trial evidence & future prospects.
Published 4 years ago • 606 plays • Length 19:05Download video MP4
Download video MP3
Similar videos
-
22:01
professor miles fisher - a diabetologist’s view of new anti-diabetic therapy.
-
8:58
professor mansoor husain - glp-1 analogues - have the limits been reached? - summary version
-
12:39
professor mansoor husain - glp-1 analogues - have the limits been reached? - full version
-
18:44
professor lars ryden - 'are pleiotropic effects of glp-1 agonists clinically important?'
-
26:43
prof melanie davies - 'do glp-1 analogues and sglt2 inhibitors have a role beyond type 2 diabetes?'
-
4:20
what is pramipexole (mirapex ®)?
-
13:15
are there natural glp-1 agonists?
-
4:25
how wegovy works: glp-1 receptor agonist explained | ami insights
-
2:36:55
day 2 complete recording
-
5:01
glp-1 receptor agonists – how weight loss injections work
-
35:43
professor cliff bailey - the diabetes therapy pipeline: what can we expect next?
-
8:13
professor mansoor husain - clinical benefit of modern therapy for type 2 diabetes – glp-1 analogues
-
36:12
novel dual gip/glp-1 receptor agonists: the future standard of diabetes care?
-
1:02:44
exploring the science and practice of glp-1 receptor agonists
-
4:38
introduction to glp-1
-
18:11
a digest of latest clinical data with glp-1 receptor agonists
-
20:47
applying guidelines and evidence to individualize t2dm treatment with glp-1 ras
-
50:21
webinar—the golden era of glp-1 drugs
-
45:29
expert insights on glp-1: transforming obesity & diabetes management
-
3:11
75th scientific sessions: glp-1 alters how the brain responds to food
-
1:31
glp 1 weight loss